Chi-Huey Wong Assesses the Progress of the Vaccine for Globo-H Cancer

Globo H is a tumour-associated carbohydrate antigen found in epithelial cells

La Jolla, CA - September 11, 2019 /MarketersMedia/ —

The World Health Organization (WHO) reported in 2018 that the 2nd cause of death on a worldwide level is cancer, with the Ischaemic heart disease being 1st. Almost 10 million people die every year due to cancer, and 70% of them live in low to middle-income countries. Most of these cancers attack lungs, breasts, colon, stomach, prostate, liver and pancreas. Acclaimed biochemist Professor Chi-Huey Wong, PhD has worked tirelessly over the course of his career in advanced research to develop effective immunotherapy treatment regimens targeting the most prevalent types of cancerous tumor growth. After more than 30 years of research conducted out of labs based in the USA, Japan and Taiwan, Dr.Wong is particularly excited by the prospects for effective therapy and suppression of cancer cells and their stem cells through the application of Globo H vaccinations.

Globo H is a tumour-associated carbohydrate antigen found in epithelial cells (plasma membrane) that was first isolated in 1983 and observed to be expressed across a variety of cancers. Its complex chemistry made it highly difficult to replicate for study, until Chi-Huey Wong designed the Optimer One-Pot Synthesis (OPopS) which allowed for a complete and rapid synthesis of Globo H and the development of one of the first carbohydrate-based cancer vaccines, specifically targeting breast cancer cells and demonstrating positive results through Phase I and II human trials. The vaccine is currently in phase III global trials conducted by the Taiwaness biopharmaceutical company OBI Pharma, Inc.

A proliferation of Globo H studies published in journals such as the US National Library of Medicine, The Journal of Ovarian Research, The National Academy of Sciences and the American Chemical Society (which published Dr.Wong’s seminal pieces “Development of Globo H Vaccine” and “Functional Study and Signaling Pathway of Globo-series Glycosphingolipids and β1,3-Galactosyltransferase V (β3GalT5) in Breast Cancer”, Proc. Nat. Acad. Sci. U.S.A., 2019, 116, 3518-23) have shown promising data indicating the role and signaling mechanism of the globo-series glycolipids in cancer progression, and the positive efficacy correlation with these markers present in many leading cancer types. These studies and human trials support not only the continued research and application of vaccination technologies, but will also serve to aid in preventive screening and identifications.

Beginning in 2018, OBI has been conducting FDA-approved Phase I clinical trials of a “novel first-in-class monoclonal antibody”—OBI 888, specifically geared as a tumour-killer that targets Globo H and has shown efficacy at shrinking cancerous growths with no adverse effects to patients. New York-based Creative Biolabs are also demonstrating major advances in similar immunotherapies, offering primary and secondary prevention regimens based on antigens found in breast and prostate cancers and small cell lung carcinomas.

With a career spanning more than three decades beginning with an M.S. in Biochemical Sciences from the National Taiwan University in 1977, a PhD in Chemistry from MIT in 1982 and a Postdoctoral Fellowship from Harvard University in 1983, Chi-Huey Wong is recognized as a pioneer in the fields of glycoscience, organic chemistry and chemical biology and has published more than 700 academic research papers as reported by Asian Scientist Newsroom. Among his many accolades are the 2015 Robert Robinson Award from the Royal Society of Chemistry, the 2014 Wolf Prize in Chemistry (cited as the most prestigious award after the Nobel Prize) and the 2012 Nikkei Prize in Science, Technology and Innovation Category. Dr.Wong currently serves as the Scripps Family Chair Professor of Chemistry at the Scripps Research Institute in California and has previously held distinguished positions with the Academia Sinica in Taiwan and the RIKEN Institute of Physical and Chemical Research in Japan.

Chi-Huey Wong On the Importance of Glycan Microarrays for Understanding Immunity:

Chi-Huey Wong Examines Methods of Automation in Oligosaccharides Synthesis:

Contact Info:
Name: CHW
Email: Send Email
Organization: Chi-Huey Wong

Source URL:

Source: MarketersMedia

Release ID: 88918048

More News

AP Exclusive: US helping Venezuela's Guaido track stolen art

Sep 22, 2019

CARACAS, Venezuela — U.S. officials are investigating the suspected looting of valuable European and Latin American artwork they believe is being quietly plundered by Venezuelan government insiders as Nicolas Maduro struggles to maintain his grip on power. The U.S. Treasury in recent months has sought the cooperation of the FBI, Italian police and museum experts to identify and locate the missing artwork. Among the objects being traced: three Venezuelan masterpieces that hung for decades on the walls of the ambassador's stately residence in Washington but which were nowhere to be found when opposition leader Juan Guaido's envoy took over the...

Bermuda lashed by heavy winds from Cat 3 Hurricane Humberto

Sep 22, 2019

MIAMI — Hurricane Humberto lashed Bermuda with strong winds Wednesday night as the powerful Category 3 storm passed just to the north of the British Atlantic territory, while another growing storm threatened tourist resorts along Mexico's Pacific coast. Bermuda Gov. John Rankin called up 120 members of the Royal Bermuda Regiment to prepare for possible storm recovery efforts and National Security Minister Wayne Caines cautioned everyone to stay inside. Authorities had ordered early closings of schools, clinics and government offices. The U.S. National Hurricane Center said hurricane-force winds began to hit the island of some 70,000 people by late afternoon...

UN: Reconstruction of landmark Mosul mosque to begin in 2020

Sep 22, 2019

PARIS — The United Nations' cultural agency says reconstruction of Al-Nouri Mosque in Iraq's old city of Mosul is scheduled to start at the beginning of next year. UNESCO chief Audrey Azoulay says rebuilding the landmark mosque once famous for its leaning minaret is part of ambitious plans to stimulate culture and revive ravaged Mosul. Islamic State group leader Abu Bakr al-Baghdadi declared an Islamic caliphate from the mosque in 2014. IS militants blew it up as Iraqi troops neared in 2017. Iraq's culture minister and other Iraqi officials were with Azoulay in Paris on Wednesday as she discussed the...

Oil drilling plan near Utah monument draws tribal opposition

Sep 22, 2019

SALT LAKE CITY — The U.S. government will allow oil and gas companies to make lease bids Monday on lands considered archaeologically sensitive near a national monument stretching across the Utah-Colorado border that houses sacred tribal sites. Included in the Bureau of Land Management's September oil and gas lease sale is about 47 square miles (122 square kilometers) of land north of Hovenweep National Monument, a group of prehistoric villages overlooking a canyon with connections to several indigenous tribes throughout the U.S. Southwest. The parcels for lease are about five to 20 miles (eight to 32 kilometers) north of the...

Mexicans mourn painter Francisco Toledo, defender of culture

Sep 22, 2019

MEXICO CITY — Mexicans left candles and flowers at impromptu offerings Friday for expressionist painter Francisco Toledo a day after his death at age 79, remembering an artist respected for his fights to preserve historic sites and green spaces. In a country where politicians talk endlessly about defending culture and identity, Toledo actually did it. He gained a reputation for never yielding to power, money or influence, and became perhaps the most revered figure of Mexico's present-day art world. His paintings were a celebration of the mystical world, the animal spirits and color of the indigenous cultures in his native...

To travel is to live. Unearth your next travel destination here with The Travel Trooper. We love what we do and looking forward to more #travelsquad joining us in this journey.

Contact us: